Global Animal-Derived Collagen Market Strategic Research Report
By Type: Gelatin, Hydrolyzed Collagen And Collagen Peptides, Native And Undenatured Collagen, Others
By Application: Food Grade, Nutraceutical Grade, Pharmaceutical and Medical Grade, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: GELITA AG, Darling Ingredients Inc. Rousselot, Nitta Gelatin Inc., Weishardt, Lapi Gelatine S.p.A., Italgel S.p.A., Trobas B.V., Nippi, Incorporated, JELLICE Co., Ltd., Ewald-Gelatine GmbH, Seagarden AS, Bioiberica S.A.U., Titan Biotech Limited, India Gelatine & Chemicals Limited, Narmada Gelatines Limited, Baotou Dongbao Bio-Tech Co., Ltd., Hainan Huayan Collagen Technology Co., Ltd., Beijing SEMNL Biotechnology Co., Ltd., Hainan Pure Peptide Technology Co., Ltd., Shandong Hengxin Biotechnology Co., Ltd., Fucheng Xushang Gelatin Co., Ltd., Zhejiang Hailisheng Biological Technology Co., Ltd., Guangzhou Trauer Biotechnology Co., Ltd., Hangzhou Nutrition Biotechnology Co., Ltd., Shandong Hailongyuan Bio-Tech Co., Ltd.
Visão geral
Scope of the Report
The global Animal-Derived Collagen market size is predicted to grow from US$ 5,311 million in 2025 to US$ 7,872 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.
Animal-Derived Collagen refers to collagen-based ingredients extracted from bovine hides and bones, porcine skins and bones, fish skins and scales, poultry cartilage, and other animal connective tissues through acid, alkaline, enzymatic or combined extraction, purification and drying processes. Depending on the degree of structural preservation and hydrolysis, the principal commercial forms include native or undenatured collagen retaining the triple-helical structure, partially hydrolyzed gelatin with gelling functionality, and further hydrolyzed collagen or collagen peptides with lower molecular weights and improved solubility.
Animal-derived collagen is widely used in food and beverages, dietary supplements, pharmaceutical excipients, capsule materials, biomedical materials, cosmetics and technical products. Product performance differs substantially in molecular weight, Bloom strength, solubility, biological activity, purity, endotoxin control and regulatory grade. This market scope covers animal-derived collagen ingredients and excludes recombinant or fermentation-derived collagen, finished dietary supplements, injectable aesthetic products and finished collagen-based medical devices.
In 2025, global Animal-Derived Collagen output was approximately 580,000 metric tons, the weighted-average price was approximately USD 8,900 per metric ton, and manufacturing gross margins were approximately 22% to 35%.
The global Animal-Derived Collagen market is evolving from a volume-oriented supply structure dominated by traditional gelatin toward higher-value collagen peptides, marine collagen, functional peptide compositions and medical-grade collagen. Gummies, pharmaceutical capsules, dairy products and confectionery continue to provide stable base demand. At the same time, healthy aging, sports nutrition, joint management, bone health and beauty-from-within trends are expanding the use of collagen peptides in dietary supplements, functional beverages, nutrition bars and specialized nutrition products. The conversion of hides, bones, fish skins and scales into high-value ingredients also gives the industry an important circular-economy role.
Competition is shifting from basic protein content and gel performance toward traceable raw materials, controlled molecular-weight distribution, characteristic peptide content, neutral taste and odour, cold-water dispersibility, acid and heat stability, and scientific evidence supporting specific functions. Bovine collagen benefits from large-scale raw-material availability and competitive costs. Porcine gelatin retains an established position in food and pharmaceutical applications, while marine collagen benefits from religious compatibility, marine-resource utilization and premium beauty-nutrition positioning. Peptides below 1 kilodalton, collagen tripeptides, undenatured type II collagen and purpose-designed bioactive peptide compositions are expected to achieve higher prices and margins than conventional hydrolyzed collagen.
The industry nevertheless faces animal-disease risks, raw-material price volatility, religious and dietary restrictions, marine odour and allergen management, wastewater treatment requirements and high energy consumption. Nutrition and beauty claims are also subject to increasingly rigorous clinical and regulatory scrutiny. Recombinant collagen and fermentation-derived proteins are beginning to compete in aesthetic medicine, biomaterials and high-purity applications. Producers with integrated raw-material sourcing, large-scale extraction, controlled enzymatic hydrolysis, regulatory certification and global distribution will remain competitive in volume markets, while companies with proprietary peptides, medical-grade purification and application research will capture higher value.
This report presents a comprehensive overview of the global Animal-Derived Collagen market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Gelatin
- Hydrolyzed Collagen And Collagen Peptides
- Native And Undenatured Collagen
- Others
Segment by Animal Source
- Bovine Collagen
- Porcine Collagen
- Marine Collagen
- Others
Segment by Commercial Grade
- Type I Collagen
- Type II Collagen
- Type III Collagen
- Others
Segment by Application
- Food Grade
- Nutraceutical Grade
- Pharmaceutical and Medical Grade
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Animal-Derived Collagen market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Food Grade, Nutraceutical Grade, Pharmaceutical and Medical Grade evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Animal-Derived Collagen Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Gelatin
- 3.1.3 Hydrolyzed Collagen And Collagen Peptides
- 3.1.4 Native And Undenatured Collagen
- 3.1.5 Others
- 3.1.6 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Food Grade
- 4.1.3 Nutraceutical Grade
- 4.1.4 Pharmaceutical and Medical Grade
- 4.1.5 Others
- 4.1.6 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 GELITA AG
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Darling Ingredients Inc. Rousselot
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Nitta Gelatin Inc.
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Weishardt
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Lapi Gelatine S.p.A.
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Italgel S.p.A.
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Trobas B.V.
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Nippi, Incorporated
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 JELLICE Co., Ltd.
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Ewald-Gelatine GmbH
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Seagarden AS
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Bioiberica S.A.U.
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Titan Biotech Limited
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 India Gelatine & Chemicals Limited
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Narmada Gelatines Limited
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Baotou Dongbao Bio-Tech Co., Ltd.
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
- 8.17 Hainan Huayan Collagen Technology Co., Ltd.
- 8.17.1 Company Overview
- 8.17.2 Key Products & Segments
- 8.17.3 Financial Performance (2023–2025)
- 8.17.4 Business Strategy
- 8.17.5 SWOT Analysis
- 8.17.6 Strategic Implications (2026–2032)
- 8.18 Beijing SEMNL Biotechnology Co., Ltd.
- 8.18.1 Company Overview
- 8.18.2 Key Products & Segments
- 8.18.3 Financial Performance (2023–2025)
- 8.18.4 Business Strategy
- 8.18.5 SWOT Analysis
- 8.18.6 Strategic Implications (2026–2032)
- 8.19 Hainan Pure Peptide Technology Co., Ltd.
- 8.19.1 Company Overview
- 8.19.2 Key Products & Segments
- 8.19.3 Financial Performance (2023–2025)
- 8.19.4 Business Strategy
- 8.19.5 SWOT Analysis
- 8.19.6 Strategic Implications (2026–2032)
- 8.20 Shandong Hengxin Biotechnology Co., Ltd.
- 8.20.1 Company Overview
- 8.20.2 Key Products & Segments
- 8.20.3 Financial Performance (2023–2025)
- 8.20.4 Business Strategy
- 8.20.5 SWOT Analysis
- 8.20.6 Strategic Implications (2026–2032)
- 8.21 Fucheng Xushang Gelatin Co., Ltd.
- 8.21.1 Company Overview
- 8.21.2 Key Products & Segments
- 8.21.3 Financial Performance (2023–2025)
- 8.21.4 Business Strategy
- 8.21.5 SWOT Analysis
- 8.21.6 Strategic Implications (2026–2032)
- 8.22 Zhejiang Hailisheng Biological Technology Co., Ltd.
- 8.22.1 Company Overview
- 8.22.2 Key Products & Segments
- 8.22.3 Financial Performance (2023–2025)
- 8.22.4 Business Strategy
- 8.22.5 SWOT Analysis
- 8.22.6 Strategic Implications (2026–2032)
- 8.23 Guangzhou Trauer Biotechnology Co., Ltd.
- 8.23.1 Company Overview
- 8.23.2 Key Products & Segments
- 8.23.3 Financial Performance (2023–2025)
- 8.23.4 Business Strategy
- 8.23.5 SWOT Analysis
- 8.23.6 Strategic Implications (2026–2032)
- 8.24 Hangzhou Nutrition Biotechnology Co., Ltd.
- 8.24.1 Company Overview
- 8.24.2 Key Products & Segments
- 8.24.3 Financial Performance (2023–2025)
- 8.24.4 Business Strategy
- 8.24.5 SWOT Analysis
- 8.24.6 Strategic Implications (2026–2032)
- 8.25 Shandong Hailongyuan Bio-Tech Co., Ltd.
- 8.25.1 Company Overview
- 8.25.2 Key Products & Segments
- 8.25.3 Financial Performance (2023–2025)
- 8.25.4 Business Strategy
- 8.25.5 SWOT Analysis
- 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Animal-Derived Collagen market size?
What growth rate is expected for the Animal-Derived Collagen market through 2032?
How is Animal-Derived Collagen defined?
What are the main segments of the Animal-Derived Collagen market by type?
Which applications drive demand in the Animal-Derived Collagen market?
Who are the key players in the Animal-Derived Collagen market?
Which regions and countries are covered for Animal-Derived Collagen?
What challenges does the Animal-Derived Collagen market face?
Who should buy the Animal-Derived Collagen market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Animal-Derived Collagen Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Chemicals & Advanced Materials